Giulia Balconi supports research efforts at Adjuvant Capital, an impact investment firm supporting life sciences technology companies focused on historically neglected diseases and maternal/child health. She holds a master's degree in Public Health from UC Berkeley.
We are at a crucial point in the fight against cholera. Despite shortages and rising demand, there is real momentum in vaccine development and production. We can’t afford to lose focus.
